Long-term Review of a Cohort of Arthroscopic Bankart Interventions (NCT03654118) | Clinical Trial Compass
CompletedNot Applicable
Long-term Review of a Cohort of Arthroscopic Bankart Interventions
France125 participantsStarted 2017-08-07
Plain-language summary
Recurrent instability is the most common chronic shoulder pathology of the young and athletic patient. It is a source of functional, sporting and professional disability, and a permanent apprehension to the use of the affected shoulder.
Surgical treatment has been proposed for a long time by the reintegration of the labrum (intervention of Bankart) then by the making of an osteo-muscular stop (intervention of Latarjet).
Like in many domains, surgical techniques have evaluated towards the search for endoscopic alternatives to open surgery, more deleterious.
Bankart's intervention has been performed arthroscopically since the 1980s and remains the majority intervention in the United States. However, its success rate never reached that of open techniques, Bankart and Latarjet. Surgeons therefore sought the predictors of these failures in order to define the limits of the indications for arthroscopic Bankart intervention.
The determination and use of the preoperative instability score (Instability Severity Index Score : ISIS) described by Balg and Boileau is one of the ways to clarify these indications.
The aim of this study is to prospectively establish the values of the ISIS score to obtain an acceptable recurrence rate of long-term instability
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Major patient
* Patient who already volunteered in a first ISIS study
Inclusion Criteria of the ISIS Study:
* Patients operated between December 2007 and December 2008 for recurrent shoulder instability, according to the arthroscopic procedure (Arthroscopic Bankart) in the investigative centers and presenting at the time of the indication of operation an ISIS score of ≤ 4 points (regardless of the positive criteria) (see Annex 2- ISIS score)
* Age\> 16 years
* Supported by a joint arthroscopic technique completed.
* Patient not objecting to his participation in the study
Exclusion Criteria (same as those of the ISIS study)
* First dislocation or resumption of another technique at the time of indication for surgery
* Voluntary or multidirectional instability at the time of the indication of operation
* Painful shoulder without instability felt at the time of the operative indication
* Lesion of the cap (perioperative report)
* Humeral lesions Avulsion Gleno-humeral Ligament (per-operative finding)
* Unsuccessful technique
* Major benefiting from a legal protection measure (safeguard of justice, trusteeship, guardianship)
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Number of instability recurrence after arthroscopic Bankart intervention
Timeframe: Through study completion, 2 months on average